In contrast, when domestic producer experience a positive sample, there is a recall. FDA charges a fee only when the producer does not cooperate with a mandatory recall. For the same situation of a positive sample, the imported product is subject to significant fees while the domestic product is subject to minimal or no fees. Accordingly, a core principle of the World Trade Organization is “national treatment.” Member countries of the WTO cannot discriminate between imported and domestic products in terms of regulatory burden and/or fees.
Do FDA rules discriminate against imports?
12/21/2011 07:04:00 AM